Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the recent launch of the Vericheck ddPCR™ Replication ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced the recent launch of the Vericheck ddPCR™ Replication Competent Lentivirus Kit and the Vericheck ddPCR Replication Competent AAV Kit. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results